US Stock MarketDetailed Quotes

CCCC C4 Therapeutics

Watchlist
  • 4.080
  • -0.060-1.45%
Close Jun 18 16:00 ET
  • 4.098
  • +0.018+0.45%
Post 19:59 ET
280.73MMarket Cap-1721P/E (TTM)

About C4 Therapeutics Company

C4 Therapeutics, Inc. engages in the development of targeted protein degradation science to develop a new generation of small molecule medicines used for treating diseases. It develops the Degronimid platform that incorporates small molecule binders to target disease-causing proteins and facilitate their destruction and clearance from the cell through the natural ubiquitin and proteasome system. The company was founded by James E. Bradner, Kenneth C. Anderson, Nathanael S. Gray and Marc A. Cohen in October 2015 and is headquartered in Watertown, MA.

Company Profile

SymbolCCCC
Company NameC4 Therapeutics
Listing DateOct 2, 2020
Issue Price19.00
Founded2015
CEOMr. Andrew J. Hirsch
MarketNASDAQ
Employees145
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address490 Arsenal Way,Suite 120
CityWatertown
ProvinceMassachusetts
CountryUnited States of America
Zip Code02472
Phone1-617-231-0700

Company Executives

  • Name
  • Position
  • Salary
  • Andrew J. Hirsch
  • Director, President and Chief Executive Officer
  • 3.46M
  • Mark Mossler
  • Chief Accounting Officer
  • --
  • Jolie M. Siegel
  • Chief Legal Officer and Secretary
  • --
  • Kelly A. Schick
  • Chief People Officer
  • --
  • Scott N. Boyle, M.B.A.,PhD
  • Chief Business Officer
  • --
  • Dr. Leonard M.J. Reyno, M.D.
  • Chief Medical Officer
  • 1.67M
  • Kendra Adams
  • Chief Financial Officer and Treasurer
  • --
  • Dr. Stewart Fisher, PhD
  • Chief Scientific Officer
  • 1.53M
  • Owen P. Hughes, Jr
  • Independent Director
  • 73.83K
  • Dr. Kenneth C. Anderson, M.D.
  • Independent Director
  • 111.41K
  • Dr. Laura Bessen, M.D.
  • Independent Director
  • 115.41K
  • Malcolm Salter
  • Independent Director
  • 121.91K
  • Bruce L. Downey
  • Independent Director
  • 157.91K
  • Utpal Koppikar
  • Independent Director
  • 126.41K
  • Dr. Donna Roy Grogan, M.D.
  • Independent Director
  • 121.41K
  • Ronald H.W. Cooper
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg